RAF inhibitor compounds

US9334267B2 · kind B2 · utility

Assignee

• Deciphera Pharmaceuticals, LLC · US

Inventors

• Daniel L. Flynn · Lawrence, US
• Michael D. Kaufman · Waltham, US
• Lakshminarayana Vogeti · Lawrence, US
• Scott Wise · Lawrence, US
• Wei Lu · Newton, US
• Bryan D. Smith · Madison, US
• James Robert Henry · Indianapolis, US
• Philip Arthur Hipskind · New Palestine, US
• Sheng-Bin Peng · Carmel, US

Key dates

• Filing date: Mar 5, 2013
• Grant date: May 10, 2016
• Expiry date: Mar 5, 2033

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D471/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

This invention provides compounds of Formula I: (Formula I should be inserted here) or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising a compound of Formula I; and use of a compound of Formula I for treating specified cancers.